Company Filing History:
2 out of 832,843 Years Active: 2005-2010
Title: The Innovations of Stanley Lorens
Introduction
Stanley Lorens is an accomplished inventor based in Forest Park, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of emotional dysfunctions and senile dementia. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Lorens' latest patents include innovative uses of glycosaminoglycans. The first patent focuses on the use of glycosaminoglycan fractions with an average molecular weight of 2400 D for the preparation of pharmaceutical compositions aimed at treating emotional dysfunctions, including depressive disorders and anxiety neurosis. The second patent addresses the use of glycosaminoglycans for treating senile dementia, specifically targeting Alzheimer's disease and related cerebral neurological lesions.
Career Highlights
Throughout his career, Stanley Lorens has demonstrated a commitment to advancing medical science. His research has led to the development of pharmaceutical compositions that could provide relief for individuals suffering from emotional and cognitive disorders. His innovative approach to utilizing glycosaminoglycans showcases his dedication to improving patient outcomes.
Collaborations
Stanley has collaborated with notable professionals in his field, including Umberto Cornelli and Luigi De Ambrosi. These partnerships have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Stanley Lorens is a notable inventor whose work in pharmaceuticals has the potential to change lives. His patents on glycosaminoglycans for treating emotional dysfunctions and senile dementia highlight his innovative spirit and commitment to improving healthcare.